Media Centre
Latest press releases
-
Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis
-
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
-
Long-term ALPHA Phase III trial data showed danicopan as add-on to Ultomiris or Soliris sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular haemolysis
-
Update on CRYSTALIZE evidence trials
-
AstraZeneca advances scientific leadership in haematology at ASH 2023
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.